Is EMGIPARA-S 250MG SUPPOSITRIES registered in Ghana?

EMGIPARA-S 250MG SUPPOSITRIES is recorded with registration status “Valid” in Ghana, registration number FDA/SD.243-020291, based on FDA Ghana data.

Who manufactures EMGIPARA-S 250MG SUPPOSITRIES?

EMGIPARA-S 250MG SUPPOSITRIES is manufactured by Meridian Enterprises.

Valid Ghana · FDA Ghana

EMGIPARA-S 250MG SUPPOSITRIES

FDA/SD.243-020291

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.

FDA/SD.243-020291

Registration date

2024-02-21

Expiry date

2027-03-01

Status

Valid

Active ingredient

Dosage form

Strength

Pack size

Therapeutic class

Manufacturer / MAH

Meridian Enterprises

Applicant / LTR

M&G PHARMACEUTICALS LIMITED

Country of origin

Manufacturer location

Embassy Centre, 1108, Jamnalal Bajaj Marg, Nariman Point, Mumbai, Maharashtra 400021, India

Source: Food and Drugs Authority · fetched 2026-04-18 08:33:00 · updated 2026-10-20 04:00:08

Disclaimer: This information is sourced from Food and Drugs Authority (Ghana). Always consult a qualified healthcare professional before using any medication.